These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 33191465)

  • 1. Synthetic analogues of memantine as neuroprotective and influenza viral inhibitors: in vitro and physicochemical studies.
    Tencheva A; Liu R; Volkova TV; Chayrov R; Mitrev Y; Štícha M; Li Y; Jiang H; Li Z; Stankova I; Perlovich GL
    Amino Acids; 2020 Dec; 52(11-12):1559-1580. PubMed ID: 33191465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-β peptide in Alzheimer's disease.
    Rosini M; Simoni E; Caporaso R; Basagni F; Catanzaro M; Abu IF; Fagiani F; Fusco F; Masuzzo S; Albani D; Lanni C; Mellor IR; Minarini A
    Eur J Med Chem; 2019 Oct; 180():111-120. PubMed ID: 31301562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memantine-sulfur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer's disease.
    Sozio P; Cerasa LS; Laserra S; Cacciatore I; Cornacchia C; Di Filippo ES; Fulle S; Fontana A; Di Crescenzo A; Grilli M; Marchi M; Di Stefano A
    Eur J Pharm Sci; 2013 May; 49(2):187-98. PubMed ID: 23454012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Amnesic and Neuroprotective Effects of Fluoroethylnormemantine in a Pharmacological Mouse Model of Alzheimer's Disease.
    Couly S; Denus M; Bouchet M; Rubinstenn G; Maurice T
    Int J Neuropsychopharmacol; 2021 Feb; 24(2):142-157. PubMed ID: 32977336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of Memantine and 6-Chlorotacrine as Novel Multi-Target Compound against Alzheimer's Disease.
    Kaniakova M; Nepovimova E; Kleteckova L; Skrenkova K; Holubova K; Chrienova Z; Hepnarova V; Kucera T; Kobrlova T; Vales K; Korabecny J; Soukup O; Horak M
    Curr Alzheimer Res; 2019; 16(9):821-833. PubMed ID: 30819076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation.
    Song MS; Rauw G; Baker GB; Kar S
    Eur J Neurosci; 2008 Nov; 28(10):1989-2002. PubMed ID: 19046381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective Effect of New Nanochelating-Based Nano Complex, ALZc3, Against Aβ
    Karimi-Sales R; Ashiri M; Hafizi M; Kalanaky S; Maghsoudi AH; Fakharzadeh S; Maghsoudi N; Nazaran MH
    Pharm Res; 2020 Feb; 37(3):48. PubMed ID: 32020309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memantine ameliorates cognitive impairment induced by exposure to chronic hypoxia environment at high altitude by inhibiting excitotoxicity.
    Ji W; Zhang Y; Luo J; Wan Y; Liu J; Ge RL
    Life Sci; 2021 Apr; 270():119012. PubMed ID: 33422543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triptolide derivatives as potential multifunctional anti-Alzheimer agents: Synthesis and structure-activity relationship studies.
    Ning C; Mo L; Chen X; Tu W; Wu J; Hou S; Xu J
    Bioorg Med Chem Lett; 2018 Feb; 28(4):689-693. PubMed ID: 29366650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation.
    Lipton SA
    Curr Drug Targets; 2007 May; 8(5):621-32. PubMed ID: 17504105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of memantine and vitamin D prevents axon degeneration induced by amyloid-beta and glutamate.
    Annweiler C; Brugg B; Peyrin JM; Bartha R; Beauchet O
    Neurobiol Aging; 2014 Feb; 35(2):331-5. PubMed ID: 24011542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memantine prodrug as a new agent for Alzheimer's Disease.
    Sestito S; Daniele S; Pietrobono D; Citi V; Bellusci L; Chiellini G; Calderone V; Martini C; Rapposelli S
    Sci Rep; 2019 Mar; 9(1):4612. PubMed ID: 30874573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
    Lipton SA
    J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
    Sonkusare SK; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possibility of a new anti-alzheimer's disease pharmaceutical composition combining memantine and vitamin D.
    Annweiler C; Beauchet O
    Drugs Aging; 2012 Feb; 29(2):81-91. PubMed ID: 22233455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40).
    Miguel-Hidalgo JJ; Alvarez XA; Cacabelos R; Quack G
    Brain Res; 2002 Dec; 958(1):210-21. PubMed ID: 12468047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-autophagic and anti-apoptotic effects of memantine in a SH-SY5Y cell model of Alzheimer's disease via mammalian target of rapamycin-dependent and -independent pathways.
    Song G; Li Y; Lin L; Cao Y
    Mol Med Rep; 2015 Nov; 12(5):7615-22. PubMed ID: 26459718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, Neuroprotective Effect and Physicochemical Studies of Novel Peptide and Nootropic Analogues of Alzheimer Disease Drug.
    Chayrov R; Volkova T; Perlovich G; Zeng L; Li Z; Štícha M; Liu R; Stankova I
    Pharmaceuticals (Basel); 2022 Sep; 15(9):. PubMed ID: 36145329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of novel azaanthraquinone derivatives as potent multi-target inhibitors of inflammation and amyloid-β aggregation in Alzheimer's disease.
    Wang J; Li W; Qin J; Wang L; Wei S; Tang H
    Bioorg Chem; 2019 Mar; 83():477-486. PubMed ID: 30448726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.
    Sánchez-López E; Ettcheto M; Egea MA; Espina M; Cano A; Calpena AC; Camins A; Carmona N; Silva AM; Souto EB; García ML
    J Nanobiotechnology; 2018 Mar; 16(1):32. PubMed ID: 29587747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.